Hussein Sweiti
CIK: 0002088436
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ENGN
enGene Holdings Inc.
Officer
Discretionary Trading P&L
Holdings
About Sweiti Hussein
Sweiti Hussein (SEC CIK 0002088436) files insider reports with the SEC as Chief Medical Officer of enGene Holdings Inc. (ENGN).
Signal8 holds 2 ownership filings by Sweiti Hussein (1 Form 3, 1 Form 4), filed on Oct 1, 2025. Those filings report 1 transaction, the latest on Sep 30, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Sweiti Hussein's filings is in SAINT-LAURENT, A8.
Recent filings by Sweiti Hussein
- Sep 30, 2025: Grant or award of ENGN derivative securities (Form 4, code A).
Other insiders filing for enGene Holdings Inc. (ENGN)
- Grossman William, Interim Chief Medical Officer
- Chinoporos Constantine, Interim Chief Business Officer
- Richton Kathleen P., SVP, Finance and Treasurer
- Astley-Sparke Philip, Director
- BRUNK GERALD A, Director
- Glickman Richard M, Director